Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM17GMN)

Drug Name

EG-011 Drug Info

Synonyms

Ad-VEGF D; Trinam-variants (refractory angina), Ark Therpeutics Group; Adenoviral short-form VEGF D gene therapy (angina/peripheral vascular disease), Ark Therapeutics; Short form VEGF-D gene therapy (refractory angina/peripheral vascular disease), Ark Therapeutics Group

Indication

Disease Entry	ICD 11	Status	REF
Angina pectoris	BA40	Discontinued in Phase 1/2	[1]

Cross-matching ID

PubChem CID: 139552342
TTD Drug ID: DM17GMN

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Vascular endothelial growth factor D (VEGFD)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
OPT-302	DMS4XFI	Diabetic macular edema	9B71.02	Phase 2	[3]
EG-016	DM7JMVR	Peripheral vascular disease	BD4Z	Discontinued in Phase 1/2	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Vascular endothelial growth factor D (VEGFD)	TTOM5H4	VEGFD_HUMAN	Modulator	[2]

------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030807)
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030807)
3	Clinical pipeline report, company report or official report of Opthea.